News & Press Releases
Filter by:
An article by Edmund Daley, Pete Michaels, and Elizabeth Platonova about a new FINRA Regulatory Notice was published by Law360. The article discusses key changes that the notice presents, including shifting a significant burden to member firms to determine when the use of negative consent is appropriate.
Bloomberg Law featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Law360 Pulse featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.
Mintz has again been ranked by Patexia, a leading intellectual property platform, in its Intelligence Report, a comprehensive list of the “best performing” and “most active” ITC Section 337 attorneys and law firms.
Sige Gutman, Life Sciences Litigation Practice Chair, shared insights with IAM in an article about a decision by the US District Court for the District of Delaware which found that a gene therapy patent of RegenxBio and the Trustees of the University of Pennsylvania was ineligible and granted summary judgement in favor of Sarepta Therapeutics.
